Difficulty: Medium
Average Score: 71%
Practice
A 45-year-old woman undergoes a complete hysterectomy for leiomyomas and dysfunctional uterine bleeding. The surgeon wants to prescribe a pain relief medication following the procedure, but the patient's serum creatinine is 1.2 mg/dL. Which of the following pain relief medications should the surgeon avoid prescribing?
Correct answer
D
Rationale
In this scenario, the correct answer is D) Ketorolac, which the surgeon should avoid prescribing to the patient with a serum creatinine of 1.2 mg/dL. Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) that is primarily eliminated by the kidneys. In patients with compromised renal function, like in this case with elevated serum creatinine, the use of ketorolac can further worsen kidney function and potentially lead to acute kidney injury.
Acetaminophen (A) is a suitable choice for pain relief in this patient as it is not primarily metabolized by the kidneys and is generally safe in renal impairment. Codeine (B) and hydrocodone (C) are opioids that are metabolized by the liver and do not rely on renal excretion. However, caution should be exercised with opioid use in patients with renal impairment due to the potential for accumulation of active metabolites.
Educationally, this question highlights the importance of considering a patient's renal function when selecting medications, especially those that are renally cleared. Understanding the pharmacokinetic profiles of different drugs in relation to renal function is crucial to prevent adverse effects and ensure safe prescribing practices. It also underscores the need for healthcare providers to individualize treatment plans based on specific patient characteristics to optimize outcomes and minimize risks.
Acetaminophen (A) is a suitable choice for pain relief in this patient as it is not primarily metabolized by the kidneys and is generally safe in renal impairment. Codeine (B) and hydrocodone (C) are opioids that are metabolized by the liver and do not rely on renal excretion. However, caution should be exercised with opioid use in patients with renal impairment due to the potential for accumulation of active metabolites.
Educationally, this question highlights the importance of considering a patient's renal function when selecting medications, especially those that are renally cleared. Understanding the pharmacokinetic profiles of different drugs in relation to renal function is crucial to prevent adverse effects and ensure safe prescribing practices. It also underscores the need for healthcare providers to individualize treatment plans based on specific patient characteristics to optimize outcomes and minimize risks.